Carboplatin News and Research

RSS
Carboplatin is a chemotherapy drug used against some forms of cancer (mainly ovarian carcinoma, lung, head and neck cancers).
ReSisTrace: Unveiling Pre-Existing Treatment Resistance in Cancer Cells

ReSisTrace: Unveiling Pre-Existing Treatment Resistance in Cancer Cells

Targeting eIF4A with Zotatifin: A Promising Strategy for TNBC Treatment

Targeting eIF4A with Zotatifin: A Promising Strategy for TNBC Treatment

Single-cell spatial analysis may provide information about neoadjuvant therapy for triple-negative breast cancer

Single-cell spatial analysis may provide information about neoadjuvant therapy for triple-negative breast cancer

New approach to identify molecular targets for improved prostate cancer therapy

New approach to identify molecular targets for improved prostate cancer therapy

Scientists find gene signature linked to worst prognosis in rare uterine cancer

Scientists find gene signature linked to worst prognosis in rare uterine cancer

Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.